Back to News
research

2026 Forecast: Don't Fight The Fed Until It's Dead

Seeking Alpha
Loading...
2 min read
2 views
0 likes
⚡ Quantum Brief
Crystal Allen608 FollowersFollow5ShareSavePlay(14min)CommentsSummaryThe Fed and Treasury's ongoing liquidity injections support short-term market gains but risk fueling a historic debt bubble.Despite rate cuts and bond buybacks, the 10-year Treasury remains unanchored, signaling diminished Fed control over long-term rates.Bear steepener formations and record-high margin and consumer debt suggest heightened risk of a severe market correction.Best strategy: increase cash and short-term Treasuries, use stop-losses, and closely monitor the 10-year Treasury for breakout signals.
2026 Forecast: Don't Fight The Fed Until It's Dead

Summarize this article with:

Crystal Allen608 FollowersFollow5ShareSavePlay(14min)CommentsSummaryThe Fed and Treasury's ongoing liquidity injections support short-term market gains but risk fueling a historic debt bubble.Despite rate cuts and bond buybacks, the 10-year Treasury remains unanchored, signaling diminished Fed control over long-term rates.Bear steepener formations and record-high margin and consumer debt suggest heightened risk of a severe market correction.Best strategy: increase cash and short-term Treasuries, use stop-losses, and closely monitor the 10-year Treasury for breakout signals. DNY59/iStock via Getty Images Since the first round of Quantitative Easing in 2008, the Fed has been medicating the stock market with loose monetary policies every time the faintest hint of a recession wafts by. This maneuver has simultaneously led toThis article was written byCrystal Allen608 FollowersFollowCrystal Allen has worked as a researcher and blog writer for a Boston-based investor relations company for the life sciences sector. She has also worked as a communications manager for a Fortune 500 database management company located in Silicon Valley. Before that she was a journalist who researched and produced stories regarding the financial implications of the health science sector, the high tech sector, and other related topics.Analyst’s Disclosure:I/we have a beneficial long position in the shares of US1M either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. The content of this article is intended for experienced investors capable of conducting their own market research and making well-informed investment decisions. This information should not be construed as advice or a recommendation for any particular security, transaction, or investment strategy. If you need investment advice, please contact a licensed financial advisor.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read Original

Source Information

Source: Seeking Alpha